Amy Schulman
InvestorManaging Partner at Polaris Partners
Mount Pleasant, South Carolina
Writes $300K – $2M checks · typically $500K
FoundedAmagma, Inc.ByHeartCyclerion TherapeuticsGlympse BioLyndraNoetik
About
Amy Schulman is a managing partner at Polaris Partners focused on healthcare companies and early stage biotech startups. She joined the firm in 2014 and co-founded the Polaris Innovation Fund in 2017, which she continues to manage. Before Polaris she held roles at Pfizer including general counsel and president of Pfizer Nutrition and Pfizer Consumer Healthcare, was a partner at DLA Piper, and began her career at Cleary Gottlieb Steen & Hamilton; she is also a Senior Lecturer at Harvard Business School and holds degrees from Wesleyan University and Yale Law School.
Invests in
BiotechHealthtech
Experience
- Romulus Central SchoolTeacher2002 — 2014
- Seneca Falls l School DistrictKindergarten teacher1999 — 2002
Deals · 11
ByHeartBoard seat
via Polaris Partners · filed May 2026 · $95.5M raise
SequelaeBoard seat
via Polaris Partners · filed Nov 2025 · $1.5M raise
QuralisBoard seat
via Polaris Partners · filed Sep 2025 · $24.9M raise
NoetikBoard seat
via Polaris Partners · filed Aug 2024 · $40M raise
LyndraBoard seat
via Polaris Partners · filed Dec 2023 · $206.1M raise
Cardurion Pharmaceuticals, Inc.Board seat
via Polaris Partners · filed Dec 2022 · $17.5M raise
Amagma, Inc.Board seat
via Polaris Partners · filed Dec 2022 · $10M raise
FractylBoard seat
via Polaris Partners · filed Jan 2022 · $20.1M raise
Glympse BioBoard seat
via Polaris Partners · filed Dec 2021 · $18M raise
Cyclerion TherapeuticsBoard seat
via Polaris Partners · filed Aug 2020 · $24.3M raise
X4 PharmaceuticalsBoard seat
via Polaris Partners · filed May 2017 · $50.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Polaris Partners
Network13
▶1 more connections
Investors connected to Amy in public investor directories — a warm-intro map.